Blood tests alone cannot diagnose cancer, but some can detect substances in your blood that suggest cancer may be present

A blood test is not a screening tool for cancer the way a mammogram or colonoscopy is. However, certain blood tests can measure tumor markers—proteins, hormones, or other substances that cancer cells release into the bloodstream. If your doctor orders one, it is usually because you already have symptoms or a reason to suspect cancer, not as a routine check.

The key limitation: tumor markers can be elevated for reasons other than cancer. An infection, inflammation, pregnancy, or benign growth can raise these numbers. A high result means your doctor will likely order imaging or a biopsy to confirm what is actually happening. A normal result does not rule out cancer either, because some cancers do not produce detectable markers.

Blood tests are most useful after a cancer diagnosis—to monitor whether treatment is working or to watch for recurrence. They are less useful as a first step when you have no symptoms.

Key Takeaways

  • Tumor markers in blood can suggest cancer is present, but they are not specific to cancer and must be followed by imaging or biopsy to confirm.
  • Different cancers produce different markers; your doctor orders the test based on your symptoms or medical history, not as a blanket screen.
  • A normal tumor marker result does not rule out cancer, because some cancers produce no detectable marker.
  • Blood tests are most reliable for monitoring cancer after diagnosis or watching for recurrence, not for initial detection.

Common tumor markers and what they measure

PSA (prostate-specific antigen) is produced by the prostate gland. Elevated PSA can indicate prostate cancer, but also benign enlargement or infection. Men over 50 (or 40 if at higher risk) may have PSA measured as part of routine screening, though debate continues about whether this prevents deaths.

CEA (carcinoembryonic antigen) is associated with colorectal cancer but can also be high in lung, breast, or ovarian cancer. It can also rise with smoking, inflammatory bowel disease, or benign polyps. CEA is often used to monitor people already diagnosed with colorectal cancer rather than to detect it initially.

CA-125 is linked to ovarian cancer but also appears in endometrial, pancreatic, and other cancers. It can also be elevated during menstruation, endometriosis, or fibroids. It is not used for routine screening because too many non-cancer conditions raise it.

HCG (human chorionic gonadotropin) and AFP (alpha-fetoprotein) are measured in blood to detect testicular and liver cancers. These are more specific than some other markers but still require imaging to confirm.

When your doctor orders a blood test for cancer

Your doctor typically orders tumor marker testing if you have symptoms that could suggest cancer—persistent fatigue, unexplained weight loss, abdominal pain, or blood in stool or urine. They may also order it if you have a family history of a specific cancer or if imaging has already found a suspicious area that needs further investigation.

If the test shows an elevated marker, your doctor will order a follow-up test to see if the level is rising, stable, or falling. A single high result is less meaningful than a trend. They will also order imaging—ultrasound, CT scan, or MRI—to look for an actual tumor. Only imaging or a tissue sample (biopsy) can confirm cancer.

Blood tests are also ordered regularly after cancer treatment to watch for recurrence. If a marker that was high before treatment drops to normal after surgery or chemotherapy, that is a good sign. If it starts rising again months or years later, it may signal that cancer has returned, prompting further investigation.

Why blood tests miss some cancers

Not all cancers produce detectable tumor markers. Some people with early-stage cancer have normal marker levels. Others have cancers that produce markers but in amounts too small to measure with standard blood tests. This is why a normal result does not mean you are cancer-free.

Additionally, tumor markers are not cancer-specific. The same marker can be elevated in multiple cancer types or in non-cancer conditions. A high PSA does not tell you whether you have prostate cancer, benign enlargement, or an infection. A high CA-125 could indicate ovarian cancer, but it could also be endometriosis or a fibroid. This is why blood tests are always paired with imaging or biopsy before any diagnosis is made.

The difference between screening and diagnostic testing

Screening means testing people with no symptoms to catch disease early. Diagnostic testing means testing someone who has symptoms or signs that suggest disease. Blood tests for tumor markers are generally diagnostic, not screening tools.

For colorectal cancer, screening means colonoscopy or stool tests, not CEA. For breast cancer, screening means mammography, not tumor markers. For ovarian cancer, there is no reliable blood screening test yet, though research continues. Blood tests enter the picture after a screening test has found something suspicious or after symptoms appear.

The exception is PSA testing in men, which is sometimes offered as screening, though major health organizations debate whether it prevents deaths or simply leads to unnecessary biopsies and treatment of slow-growing cancers.

What happens after an abnormal blood test result

An elevated tumor marker is not a diagnosis. It is a signal to investigate further. Your doctor will typically order imaging—usually a CT scan, ultrasound, or MRI depending on which cancer type is suspected. They may also repeat the blood test to see if the level is changing.

If imaging shows a suspicious mass, your doctor will likely recommend a biopsy, in which a small tissue sample is removed and examined under a microscope. Only a biopsy can confirm whether cells are cancerous. Until then, you have an abnormal result that requires follow-up, not a cancer diagnosis.

The waiting period between an abnormal test and a biopsy or imaging result can be stressful. It is reasonable to ask your doctor what the next step is, how soon it will happen, and what the possible outcomes are. Many abnormal results turn out to be benign.

Blood tests for genetic cancer risk

A different type of blood test can detect inherited genetic mutations that raise your cancer risk—such as BRCA1 and BRCA2 mutations linked to breast and ovarian cancer, or Lynch syndrome mutations linked to colorectal cancer. These tests do not diagnose cancer; they show whether you carry a gene variant that increases your lifetime risk.

Genetic testing is usually offered to people with a strong family history of cancer or to those already diagnosed with cancer at a young age. A positive genetic test means you may benefit from more frequent screening, preventive surgery, or other risk-reduction strategies. Genetic counseling before and after testing helps you understand what the results mean for your health and your family.

Frequently Asked Questions

Can a normal blood test rule out cancer?

No. A normal tumor marker result does not rule out cancer because some cancers produce no detectable marker, or the cancer is too early-stage to produce measurable amounts. If you have symptoms, your doctor will order imaging or other tests regardless of blood test results.

How often should I have tumor marker blood tests?

If you have no symptoms or family history of cancer, routine tumor marker screening is not recommended by major health organizations. If you have been diagnosed with cancer, your oncologist will determine how often to test based on your treatment plan and risk of recurrence.

Can I request a blood test to screen for cancer?

You can ask your doctor, but they will likely explain that blood tests are not reliable screening tools for most cancers. If you have risk factors or symptoms, they may order one. For screening, standard tests like colonoscopy, mammography, or Pap smears are more effective.

What if my tumor marker is slightly elevated but imaging shows nothing?

Your doctor will likely repeat the blood test in a few weeks to see if the level is rising, stable, or falling. A single mildly elevated result is often benign. If the level rises on repeat testing, further imaging or biopsy may be needed. If it stays stable or falls, no further action is usually taken.

Does a blood test for cancer hurt or have side effects?

A standard blood draw is a quick needle stick with minimal discomfort. Some people feel lightheaded or have slight bruising at the site. There are no other side effects. The results take a few days to a week depending on the lab.